Horizon Discovery competitors

Horizon Discovery Competitors include Opko Health, Interpace Diagnostics, Advanced Analytical Technologies and Cambridge Epigenetix.
Add company...
Horizon Discovery
Horizon supplies genetically-defined cell lines, in vivo models, reference standards & contract research services to academia & biopharma.
Opko Health
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Interpace Diagnostics
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
Advanced Analytical Technologies
Advanced Analytical Technologies develops, manufactures and markets high-throughput, fully-automated nucleic acid and genetic analysis systems.
Cambridge Epigenetix
Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic
Founding Date
Founding Date
2005
Founding Date
2007
Founding Date
1987
Founding Date
1998
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Waterbeach, GB HQ
Wien, AT
St. Louis, US
Cambridge, US
Boyertown, US
Locations
Miami, US HQ
Woburn, US
Locations
Parsippany-Troy Hills, US HQ
Locations
Ankeny, US HQ
Évry, FR
Heidelberg, DE
Milton Keynes, GB
Locations
Great Shelford, GB HQ
Employees
Employees
28817% increase
Employees
6,041
Employees
61
Employees
N/A
Employees
43
Valuation ($)
Valuation ($)
326.7 m
Valuation ($)
1.8 b
Valuation ($)
33 m
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
4.7 k
Facebook likes
112
Facebook likes
149
Facebook likes
393
Facebook likes
N/A
Twitter followers
Twitter followers
3.1 k
Twitter followers
N/A
Twitter followers
142
Twitter followers
318
Twitter followers
1.5 k

Financial

Revenue (est.)
Revenue (est.)
£36.5m (FY, 2017)
Revenue (est.)
$1.1b (FY, 2017)
Revenue (est.)
$15.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
£13.8m (FY, 2017)
Cost of goods
N/A
Cost of goods
$7.4m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
£22.7m (FY, 2017)
Gross profit
N/A
Gross profit
$8.5m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(£9.7m) (FY, 2017)
Net income
($308.9m) (FY, 2017)
Net income
($12.2m) (FY, 2017)
Net income
N/A
Net income
(£86.2k) (FY, 2012)

Funding

Total funding raised
Total funding raised
$ 50.2m
Total funding raised
$ 31m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 26.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Opko Health
HQ
Miami, US
Employees
6,041

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.

View company
Interpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
61

Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.

View company
Advanced Analytical Technologies
HQ
Ankeny, US

Advanced Analytical Technologies develops, manufactures and markets high-throughput, fully-automated nucleic acid and genetic analysis systems.

View company
Cambridge Epigenetix
HQ
Great Shelford, GB
Employees
43

Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic

View company